577
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

The prognostic implications of tetraploidy/near-Tetraploidy in acute myeloid leukemia: a case series and systematic review of the literature

ORCID Icon, , , , , , , , , ORCID Icon & show all
Pages 203-210 | Received 05 Jun 2020, Accepted 22 Aug 2020, Published online: 29 Sep 2020

References

  • McGowan-Jordan J, Simons A, Schmid M. ISCN: an international system for human cytogenomic nomenclature (2016). Basel, Switzerland; New York: Karger; 2016.
  • Pui CH, Carroll AJ, Head D, et al. Near-triploid and near-tetraploid acute lymphoblastic leukemia of childhood. Blood. 1990;76(3):590–596.
  • Khan AM, Munir A, Asrani R, et al. Acute myeloid leukemia with philadelphia chromosome, near-tetraploidy, and 5q deletion. Cureus. 2019;11(9):e5606.
  • Dohner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424–447.
  • Pang CS, Pettenati MJ, Pardee TS. Clinicopathological analysis of near-tetraploidy/tetraploidy acute myeloid leukaemia. J Clin Pathol. 2015;68(3):236–240.
  • Yang R, Jiang M, Zhao J, et al. Identification of chromosomal abnormalities and genomic features in near-triploidy/tetraploidy-acute leukemia by fluorescence in situ hybridization. Cancer Manag Res. 2019;11:1559–1567.
  • Lazarevic V, Rosso A, Juliusson G, et al. Prognostic significance of high hyperdiploid and triploid/tetraploid adult acute myeloid leukemia. Am J Hematol. 2015;90(9):800–805.
  • Huang L, Wang SA, DiNardo C, et al. Tetraploidy/near-tetraploidy acute myeloid leukemia. Leuk Res. 2017;53:20–27.
  • Iyer RV, Sait SNJ, Matsui S-I, et al. Massive hyperdiploidy and tetraploidy in acute myelocytic leukemia and myelodysplastic syndrome. Cancer Genet Cytogenet. 2004;148(1):29–34.
  • Xue Y, He J, Wang Y, et al. Secondary near-pentaploidy and/or near-tetraploidy characterized by the duplication of 8;21 translocation in the M2 subtype of acute myeloid leukemia. Int J Hematol. 2000;71(4):359–365.
  • Xiao Z, Liu S, Liu X, et al. Tetraploidy or near-tetraploidy clones with double 8;21 translocation: a non-random additional anomaly of acute myeloid leukemia with t(8;21)(q22;q22). Haematologica. 2005;90(3):413–414.
  • Testa JR, Oguma N, Pollak A, et al. Near-tetraploid clones in acute leukemia. Blood. 1983;61(1):71–78.
  • Abe R, Raza A, Preisler HD, et al. Chromosomes and causation of human cancer and leukemia. LIV. Near-tetraploidy in acute leukemia. Cancer Genet Cytogenet. 1985;14(1–2):45–59.
  • Xue Y, Pan Y, Liu Z, et al. Tetraploid or near-tetraploid clones characterized by two 8;21 translocations and other chromosomal abnormalities in two patients with acute myeloblastic leukemia. Cancer Genet Cytogenet. 1996;92(1):18–23.
  • Yamamoto K, Nagata K, Kida A, et al. CD7+ near-tetraploid acute myeloblastic leukemia M2 with double t(8;21)(q22;q22) translocations and Aml1/ETO rearrangements detected by fluorescence in situ hybridization analysis. Int J Hematol. 2001;74(3):316–321.
  • Li L, Li J, Li G, et al. A tetraploid minimally differentiated acute myeloblastic leukemia with extensive erythrophagocytosis: a case report and literature review. Int J Hematol. 2012;96(6):801–805.
  • Yeh SP, Wang Y, Su J, et al. Near-tetraploid minimally differentiated acute myeloid leukemia with extensive erythrophagocytosis by leukemic blasts. Ann Hematol. 2000;79(1):36–39.
  • Sharma M, Dayama A, Jain S, et al. AML associated with extensive erythrophagocytosis and tetraploidy. Eur J Haematol. 2011;87(3):286.
  • Bene MC, Castoldi G, Derolf A, et al. Near-tetraploid acute myeloid leukemias: an EGIL retrospective study of 25 cases. Leukemia. 2006;20(4):725–728.
  • Watanabe A, Inokuchi K, Yamaguchi H, et al. Near-triploidy and near-tetraploidy in hematological malignancies and mutation of the p53 gene. Clin Lab Haematol. 2004;26(1):25–30.
  • Lemez P, Zemanová Z, Marinov I, et al. Unusually long survival of a 67-year-old patient with near-tetraploid acute myeloid leukemia m0 without erythroblastic and megakaryocytic dysplasia. Acta Haematol. 2011;126(3):129–134.
  • Lemez P, Michalová K, Zemanová Z, et al. Three cases of near-tetraploid acute myeloid leukemias originating in pluripotent myeloid progenitors. Leuk Res. 1998;22(7):581–588.
  • Zelante L, Perla G, Bodenizza C, et al. Tetraploidy (92,XXYY) in an acute nonlymphocytic leukemia (M1) patient following autologous bone marrow transplantation. Cancer Genet Cytogenet. 1988;36(1):69–75.
  • Trujillo JM, Cork A, Drewinko B, et al. Case report: tetraploid leukemia. Blood. 1971;38(5):632–637.
  • Yamaguchi H, Inokuchi K, Yokomizo E, et al. Philadelphia chromosome-positive acute myeloid leukemia with tetraploidy. Int J Hematol. 2002;75(1):63–66.
  • Jurisic V, Pavlović S, Colović N, et al. Single institute study of FLT3 mutation in acute myeloid leukemia with near tetraploidy in Serbia. J Genet. 2009;88(2):149–152.
  • Jarosova M, Nedomova R, Hubacek J, et al. Rare tetraploidy with large 5q deletion in acute myeloid leukemia with myelodysplasia-related changes (AML-MRC). Leuk Res. 2012;36(4):e68.
  • Clarke MR, Lynch EF, Contis LC, et al. Near-tetraploidy in adult acute myelogenous leukemia. Cancer Genet Cytogenet. 1996;86(2):107–115.
  • Gundimeda SD, Ahmed F, Mundada MC, et al. A near tetraploid clone in acute myeloid leukemia with CD56 expression. J Cancer Res Ther. 2014;10(1):187–190.
  • Zhang JH, Zheng YC, Wang YX, et al. Laboratory study on near-tetraploid acute myelogenous leukemia of childhood. Zhongguo Dang Dai Er Ke Za Zhi. 2009;11(4):263–266.
  • Rohon P, Nedomova R, Prekopova I, et al. Acute myeloid leukemia with minimal differentiation: unusual cytogenetics, morphology, phenotype and clinical course. Leuk Res. 2012;36(7):e133.
  • Wafa A, ALmedania S, Aljapawe A, et al. A new adult AML case with an extremely complex karyotype, remission and relapse combined with high hyperdiploidy of a normal chromosome set in secondary AML. BMC Hematol. 2018;18:21.
  • Takahashi T, Ishiguro K, Maruyama Y, et al. Near tetraploidy acute myeloid leukemia in long-term remission with persistent clonal hematopoiesis with del(20)(q12q13). Intern Med, 2017.
  • Vanegas YAM, Azzouqa A-GM, Menke DM, et al. Myelodysplasia-related acute myeloid leukemia and acute promyelocytic leukemia: concomitant occurrence of two molecularly distinct diseases. Hematol Rep. 2018;10(3):7658.
  • Vilches AS, de Bustamante AD, Sanchez-Calero J, et al. Tetraploidy acute myeloid leukaemia after chromosome 16 inversion. BMJ Case Rep. 2017;2017:bcr2017219274.
  • Garson OM. Acute non-lymphocytic leukaemia. Clin Haematol. 1980;9(1):39–54.
  • Lemez P, Jelínek J, Michalová K, et al. Near-tetraploid poorly differentiated acute myeloid leukemia M0 diagnosed by short-term cultures with a phorbol ester TPA. Leuk Res. 1994;18(7):493–497.
  • Byrd JC. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood. 2002;100(13):4325–4336.
  • Cheung E, Perissinotti AJ, Bixby DL, et al. The leukemia strikes back: a review of pathogenesis and treatment of secondary AML. Ann Hematol. 2019;98(3):541–559.
  • Eisfeld A-K, Kohlschmidt J, Mrózek K, et al. Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies. Leukemia. 2018;32(6):1338–1348.
  • Herold T, Rothenberg-Thurley M, Grunwald VV, et al. Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia. Leukemia. 2020. DOI:https://doi.org/10.1038/s41375-020-0806-0
  • Harada Y, Nagata Y, Kihara R, et al. Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study. Leuk Res. 2018;66:20–27.
  • Othus M, Estey EH, Garcia-Manero G, et al. Second cycle remission achievement with 7 + 3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials. Leukemia. 2019;33(2):554–558.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.